Cargando…

Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling

Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrat...

Descripción completa

Detalles Bibliográficos
Autores principales: van Gent, Michiel, Braem, Steven G. E., de Jong, Annemieke, Delagic, Nezira, Peeters, Janneke G. C., Boer, Ingrid G. J., Moynagh, Paul N., Kremmer, Elisabeth, Wiertz, Emmanuel J., Ovaa, Huib, Griffin, Bryan D., Ressing, Maaike E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930590/
https://www.ncbi.nlm.nih.gov/pubmed/24586164
http://dx.doi.org/10.1371/journal.ppat.1003960
_version_ 1782304551168114688
author van Gent, Michiel
Braem, Steven G. E.
de Jong, Annemieke
Delagic, Nezira
Peeters, Janneke G. C.
Boer, Ingrid G. J.
Moynagh, Paul N.
Kremmer, Elisabeth
Wiertz, Emmanuel J.
Ovaa, Huib
Griffin, Bryan D.
Ressing, Maaike E.
author_facet van Gent, Michiel
Braem, Steven G. E.
de Jong, Annemieke
Delagic, Nezira
Peeters, Janneke G. C.
Boer, Ingrid G. J.
Moynagh, Paul N.
Kremmer, Elisabeth
Wiertz, Emmanuel J.
Ovaa, Huib
Griffin, Bryan D.
Ressing, Maaike E.
author_sort van Gent, Michiel
collection PubMed
description Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts.
format Online
Article
Text
id pubmed-3930590
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39305902014-02-25 Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling van Gent, Michiel Braem, Steven G. E. de Jong, Annemieke Delagic, Nezira Peeters, Janneke G. C. Boer, Ingrid G. J. Moynagh, Paul N. Kremmer, Elisabeth Wiertz, Emmanuel J. Ovaa, Huib Griffin, Bryan D. Ressing, Maaike E. PLoS Pathog Research Article Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts. Public Library of Science 2014-02-20 /pmc/articles/PMC3930590/ /pubmed/24586164 http://dx.doi.org/10.1371/journal.ppat.1003960 Text en © 2014 van Gent et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
van Gent, Michiel
Braem, Steven G. E.
de Jong, Annemieke
Delagic, Nezira
Peeters, Janneke G. C.
Boer, Ingrid G. J.
Moynagh, Paul N.
Kremmer, Elisabeth
Wiertz, Emmanuel J.
Ovaa, Huib
Griffin, Bryan D.
Ressing, Maaike E.
Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
title Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
title_full Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
title_fullStr Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
title_full_unstemmed Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
title_short Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
title_sort epstein-barr virus large tegument protein bplf1 contributes to innate immune evasion through interference with toll-like receptor signaling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930590/
https://www.ncbi.nlm.nih.gov/pubmed/24586164
http://dx.doi.org/10.1371/journal.ppat.1003960
work_keys_str_mv AT vangentmichiel epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT braemstevenge epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT dejongannemieke epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT delagicnezira epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT peetersjannekegc epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT boeringridgj epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT moynaghpauln epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT kremmerelisabeth epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT wiertzemmanuelj epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT ovaahuib epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT griffinbryand epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling
AT ressingmaaikee epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling